The in vivo radiosensitizing effect of gold nanoparticles based MRI contrast agents.
|
| Abstract |
Owing to the high atomic number (Z) of gold element, the gold nanoparticles appear as very promising radiosensitizing agents. This character can be exploited for improving the selectivity of radiotherapy. However, such an improvement is possible only if irradiation is performed when the gold content is high in the tumor and low in the surrounding healthy tissue. As a result, the beneficial action of irradiation (the eradication of the tumor) should occur while the deleterious side effects of radiotherapy should be limited by sparing the healthy tissue. The location of the radiosensitizers is therefore required to initiate the radiotherapy. Designing gold nanoparticles for monitoring their distribution by magnetic resonance imaging (MRI) is an asset due to the high resolution of MRI which permits the accurate location of particles and therefore the determination of the optimal time for the irradiation. We recently demonstrated that ultrasmall gold nanoparticles coated by gadolinium chelates (Au@DTDTPA-Gd) can be followed up by MRI after intravenous injection. Herein, Au@DTDTPA and Au@DTDTPA-Gd were prepared in order to evaluate their potential for radiosensitization. Comet assays and in vivo experiments suggest that these particles appear well suited for improving the selectivity of the radiotherapy. The dose which is used for inducing similar levels of DNA alteration is divided by two when cells are incubated with the gold nanoparticles prior to the irradiation. Moreover, the increase in the lifespan of tumor bearing rats is more important when the irradiation is performed after the injection of the gold nanoparticles. In the case of treatment of rats with a brain tumor (9L gliosarcoma, a radio-resistant tumor in a radiosensitive organ), the delay between the intravenous injection and the irradiation was determined by MRI.
|
|---|---|
| Authors | Imen Miladi, Christophe Alric, Sandrine Dufort, Pierre Mowat, Aurélie Dutour, Céline Mandon, Gautier Laurent, Elke Bräuer-Krisch, Nirmitha Herath, Jean-Luc Coll, Marie Dutreix, François Lux, Rana Bazzi, Claire Billotey, Marc Janier, Pascal Perriat, Géraldine Le Duc, Stéphane Roux, Olivier Tillement |
| Journal | Small (Weinheim an der Bergstrasse, Germany) (Small) Vol. 10 Issue 6 Pg. 1116-24 (Mar 26 2014) ISSN: 1613-6829 [Electronic] Germany |
| PMID | 24659273 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't) |
| Chemical References |
|
| Topics |
|
Join CureHunter, for free Research Interface BASIC access!
Realize the full power of the drug-disease research graph!